Rouan Sarah Kathryn
Insider CIK 1761366 · VKTX Director · NAVB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 20,400 | — | $0 | 20,400 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 3,150 | — | $0 | 4,390 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | P Buy | 2025-03-31 | 2025-04-02 | 1,240 | $24.15 | $29.9K | 1,240 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | P Buy | 2025-03-31 | 2025-04-08 | 1,240 | $24.15 | $29.9K | 1,240 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 18,800 | — | $0 | 18,800 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-10-25 | 2024-10-25 | 11,000 | — | $0 | 11,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-25 | 2024-10-25 | 11,000 | $80.89 | $889.8K | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-10-25 | 2024-10-25 | 11,000 | $4.88 | $53.7K | 11,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-02-08 | 2024-02-08 | 25,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-08 | 25,000 | $28.05 | $701.3K | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-02-08 | 2024-02-08 | 25,000 | $8.32 | $208.0K | 25,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-01-19 | 2024-01-19 | 30,000 | — | $0 | 25,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-01-19 | 2024-01-19 | 30,000 | $8.32 | $249.6K | 30,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-01-19 | 2024-01-19 | 30,000 | $23.05 | $691.5K | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 32,000 | — | $0 | 32,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2021-06-30 | 2021-07-07 | 4,892 | — | $0 | 18,242 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2021-01-13 | 2021-01-14 | 2,500 | — | $0 | 2,500 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2021-01-13 | 2021-01-14 | 2,500 | — | $0 | 13,350 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2020-02-06 | 2020-02-07 | 2,500 | — | $0 | 7,500 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2020-02-06 | 2020-02-07 | 2,500 | — | $0 | 10,850 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2019-07-01 | 2019-07-02 | 55,000 | — | $0 | 55,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | P Buy | 2019-05-17 | 2019-05-21 | 3,350 | $1.46 | $4.9K | 8,350 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2019-02-07 | 2019-02-12 | 50,000 | — | $0 | 100,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2019-02-07 | 2019-02-12 | 50,000 | — | $0 | 100,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award deriv | 2019-01-02 | 2019-01-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NAVB NAVIDEA BIOPHARMACEUTICALS | A Award | 2019-01-02 | 2019-01-03 | 50,000 | — | $0 | 50,000 | SEC↗ |